abstract |
The present invention provides a novel substituted heterocyclic compound represented by formula (I), or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds of the present invention can be used as inhibitors of RIPK1 and methods of treatment. [Formula I] |